Tobacco smoking remains a number one preventable risk factor of premature death worldwide. Findings of recent research show concurrent trends of lung cancer deaths in males and females in Europe. Although lung cancer death rates are consistently decreasing in male population, in women an upward trend is observed. The burden of tobacco-related harm can be prevented by smoking cessation. The main goal of this analysis is to identify the crucial correlates of successful smoking cessation in the middle-aged Polish population. The data came from 13 172 survey participants south-eastern part of Poland as part of the PONS cohort study established in 2010. A total of 6998 records of those who were either ex-smokers or current smokers at baseline were analyzed. We applied logistic regression and adjusted for sociodemographic covariates and health determinants. Characteristics related to being an ex-smoker as opposed to a current smoker included: older age [men: odds ratio (OR)=1.03, 95% confidence interval (CI)=1.01–1.05; women: OR=1.05, 95% CI=1.03–1.07], being married or living together, having secondary (OR=1.51, 95% CI=1.14–1.99) or higher (OR=2.30, 95% CI=1.75–3.18) education (women), full-time employment (men), alcohol consumer (women), being overweight (men: OR=2.85, 95% CI=2.26–3.59; women: OR=1.60, 95% CI=1.36–1.87) or obese (men: OR=3.47, 95% CI=2.67–4.51; women: OR=2.99, 95% CI=2.45–3.65), having normal fasting glucose and cholesterol blood level without any treatment (women), assessing their own health highly (9–10, on the scale from 1 to 10) and having at least one accompanying chronic disease (women, OR=1.25, 95% CI=1.07–1.45). These findings provide valuable information on characteristics of ex-smokers as well as behavioral and sociodemographic predictors of successful cessation. Such data expand our knowledge and can be used to design a more comprehensive and targeted group-specific tobacco control policy focused on increasing the number of ex-smokers. Correspondence to Marta Manczuk, PhD, Department of Cancer Epidemiology and Prevention, Maria-Sklodowska-Curie Cancer Center and Institute of Oncology, Ul. Wawelska 15B, 02-034 Warszawa, Poland Tel: +48 225 709 482; fax: +48 226 439 234; e-mail: marta.manczuk@coi.pl Received March 31, 2017 Accepted December 11, 2017 Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2DBm94s
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Pulmonary complications post hematopoietic stem cell transplant in dyskeratosis congenita: analysis of oxidative stress in lung fibrobl...
-
Predictive Success Factors in Selective Upper Airway Stimulation. ORL J Otorhinolaryngol Relat Spec. 2017 Feb 24;79(1-2):121-128 Auth...
-
Background. Antitumor necrosis factor (anti-TNF) therapy is a highly effective but costly treatment for inflammatory bowel disease (IBD). Me...
-
Abstract Nonmotor symptoms (NMS) have been described in several neurodegenerative diseases but have not been systematically evaluated in sp...
-
Abstract Background The introduction of aggressive chemo-radiotherapy regimens has improved overall survival in children with primitive ...
-
6 Top Reference Sites to Write a Winning Research Paper . Tina 6 Top Reference Sites to Write a Winning Research Paper. There may be guideli...
-
Elementary school kids, on the other hand, can read, write, reason and think highly complex thoughts. Adele Faber and Elaine Mazlish, author...
-
by Mindaugas Paužuolis, Torsten Eich, Joachim Burman Background Natalizumab (NTZ) is a drug that has been widely used in the treatment of m...
-
Abstract Purpose To develop the first photoactive biomaterial coating capable of controlled drug dosing via inclusion of synthesised drug-...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου